D I Marks Selected Research

D I Marks Research Topics

Disease

8	Infections 02/2016 - 12/2000
3	Leukemia 03/2017 - 10/2004
2	Multiple Myeloma 12/2015 - 09/2011
2	Residual Neoplasm 03/2014 - 10/2006
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2014 - 04/2008
2	Neoplasms (Cancer) 03/2013 - 07/2003
2	Human Influenza (Influenza) 01/2012 - 01/2002
1	Pneumonia (Pneumonitis) 04/2016
1	Mucormycosis 02/2016
1	Fusariosis 02/2016
1	Hodgkin Disease (Hodgkin's Disease) 11/2015
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 08/2015
1	Hematologic Neoplasms (Hematological Malignancy) 08/2015
1	Philadelphia Chromosome 03/2014
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2014
1	Splenomegaly 06/2013
1	Second Primary Neoplasms (Neoplasms, Second) 03/2013
1	Primary Myelofibrosis (Myelosclerosis) 11/2010
1	Multiple Sclerosis 06/2010
1	Stenotrophomonas maltophilia bacteremia 06/2010
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2007
1	Lymphoma (Lymphomas) 09/2007
1	Neutropenia 11/2004
1	Pathologic Complete Response 10/2004
1	Bronchiolitis Obliterans Syndrome 02/2004
1	Fever (Fevers) 02/2004
1	Hypotension (Low Blood Pressure) 02/2004
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2003
1	Mycoses (Diseases, Fungus) 04/2001
1	Thrombotic Thrombocytopenic Purpura 04/2001
1	Disease Progression 12/2000
1	Adenoviridae Infections (Adenovirus Infections) 12/2000
1	Aspergillosis 05/2000
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2000
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2000
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2000

Drug/Important Bio-Agent (IBA)

3	Alemtuzumab (Campath)FDA Link 05/2009 - 01/2000
2	3,4,3',4'-tetrachloroazobenzeneIBA 01/2004 - 07/2003
1	Antifungal AgentsIBA 02/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2015
1	Prostaglandins FIBA 08/2015
1	Imatinib Mesylate (Gleevec)FDA Link 03/2014
1	Tyrosine Kinase InhibitorsIBA 03/2014
1	Rituximab (Mabthera)FDA Link 02/2014
1	Dihydrotachysterol (AT 10)IBA 03/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2004
1	C-Reactive ProteinIBA 02/2004
1	SteroidsIBA 02/2004
1	Zanamivir (Relenza)FDA Link 01/2002
1	thiamine triphosphorate (TTP)IBA 04/2001
1	Ribavirin (Virazole)FDA LinkGeneric 12/2000
1	Antiviral Agents (Antivirals)IBA 12/2000
1	Cidofovir (Vistide)FDA Link 12/2000
1	antineoplaston A10 (A 10)IBA 12/2000
1	AntigensIBA 05/2000
1	LatexIBA 05/2000
1	Indicators and Reagents (Reagents)IBA 05/2000
1	ImmunosorbentsIBA 05/2000
1	EnzymesIBA 05/2000

Therapy/Procedure

8	Cell Transplantation 04/2016 - 03/2013
5	Transplantation 03/2017 - 01/2000
5	Therapeutics 09/2011 - 12/2003
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2008 - 01/2000
4	Drug Therapy (Chemotherapy) 12/2015 - 10/2006
3	Homologous Transplantation 03/2014 - 10/2004
3	Stem Cell Transplantation 01/2004 - 04/2001
2	Hematopoietic Stem Cell Transplantation 04/2016 - 08/2013
1	Autologous Transplantation 11/2015
1	Splenectomy 06/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2010
1	Chemoradiotherapy 10/2006
1	Immunotherapy 10/2006
1	Plasmapheresis 04/2001
1	Immunomodulation 12/2000
1	Remission Induction 01/2000